The conundrum of interleukin-6 blockade in COVID-19
Corrado Campochiaro, Lorenzo Dagna
Topics & Concepts
Cytokine release syndromeMedicineImmunologyBlockadeCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)TocilizumabCoronavirusMacrophage activation syndrome2019-20 coronavirus outbreakCytokineT cellReceptorChimeric antigen receptorVirologyImmune systemInternal medicineRheumatoid arthritisDiseaseArthritisOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders ResearchLong-Term Effects of COVID-19